Innate Pharma GAAP EPS of €0.02, revenue of €40.2M (NASDAQ:IPHA) September 14, 2023September 14, 2023 · Business · By ReportWire Innate Pharma GAAP EPS of €0.02, revenue of €40.2M Source link
